LRRK2 and Parkinson disease: In our study, one proband (0.35%) carried the LRRK2 p.(Gly2019Ser) variant, the most common PD-associated LRRK2 variant internationally, exceeding a frequency of 1.0% among PD patients in 26 out of 51 countries [43].